Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally ...

The study (not funded by Medtronic) enrolled 146 healthy subjects in the 92-96% saturation range and examined paired readings from Nellcor™ N-595 and Masimo Radical 7™* pulse oximeters ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

It was hard to miss CoCo Vandeweghe’s commercial for the Masimo MightySat during Indian Wells. The 30-second ad for the newly released fingertip pulse oximeter played on nearly every changeover.

Apple convinced a federal jury on Friday that health monitoring tech company Masimo’s smartwatches infringe two of its design patents. The jury, in Delaware, agreed with Apple that Masimo ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

4 analysts have expressed a variety of opinions on Masimo MASI over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their ...

Masimo (MASI) shares soared 8.7% in the last trading session to close at $121.42. The move was backed by solid volume with far more shares changing hands than in a normal session.

Masimo announced that its CEO Joe Kiani informed the board of directors that he has stepped down from his post. He was replaced by board member Michelle Brennan on an interim basis. The change is ...

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2024-11-05. Here's what investors need to know before the announcement. Analysts estimate that Masimo will ...